WST West Pharmaceutical Services, Inc.
Stable Earnings Power
B- 67.7 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
C 56
  • 5yr Avg ROIC 14.9%
  • Operating Margin Trend -1.93 pp/yr

Capital Efficiency

Weight: 15%
A- 85
  • 5yr Avg ROE 17.8%
  • 5yr Share-Count CAGR -1.2%

Growth Quality

Weight: 15%
D 36
  • 5yr Revenue CAGR 2.1%
  • 5yr EPS CAGR -5.9%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
B 73
  • 5yr FCF Margin 13.2%
  • 5yr FCF/NI Conversion 0.69x

Balance Sheet

Weight: 20%
A+ 99
  • Net Debt / EBITDA -0.52x
  • Interest Coverage (EBIT/Int) 998.67x
  • Altman Z-Score 15.55

Stability

Weight: 15%
C 51
  • EPS Volatility (σ/μ) 0.57
  • Piotroski F-Score 6
  • Negative-Revenue Years (5) 1/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

5 of 5 gurus held; 5 added.

Holders
5 +1
Avg Δ position
+6227.3%
New buys
0
Full exits
0
As of Q1 2026